tm
Seeing Is Believing
tm
Seeing Is Believing
RLMD is currently covered by 7 analysts with an average price target of $13.98. This is a potential upside of $10.12 (262.18%) from yesterday's end of day stock price of $3.86.
Relmada Therapeutics's activity chart (see below) currently has 12 price targets and 25 ratings on display. The stock rating distribution of RLMD is 58.33% BUY and 41.67% HOLD.
Analysts average stock forecasts to be materialized ratio is 13.1% with an average time for these price targets to be met of 12.43 days.
Highest price target for RLMD is $32, Lowest price target is $2, average price target is $13.98.
Most recent stock forecast was given by VAMIL DIVAN from GUGGENHEIM on 10-Aug-2023. First documented stock forecast 16-Dec-2019.
Currently out of the existing stock ratings of RLMD, 7 are a BUY (58.33%), 5 are a HOLD (41.67%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
8 months 14 days ago
0/1 (0%)
$30.5 (156.41%)
Buy
10
$6.13 (158.40%)
1 years 3 months 1 days ago
1/3 (33.33%)
$5.58 (126.24%)
47
Hold
4
$-2.8 (-41.18%)
10
1 years 4 months 16 days ago
1/4 (25%)
$1.83 (84.33%)
35
Hold
8
$4.13 (106.72%)
81
1 years 6 months 10 days ago
0/3 (0%)
$1.8 (29.03%)
Hold
8
$4.13 (106.72%)
75
1 years 6 months 11 days ago
0/3 (0%)
$1.52 (23.46%)
What is RLMD (Relmada Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on RLMD (Relmada Therapeutics) with a proven track record?
Which analyst has the current lower performing score on RLMD (Relmada Therapeutics) with a proven track record?
Which analyst has the most public recommendations on RLMD (Relmada Therapeutics)?
Which analyst is the currently most bullish on RLMD (Relmada Therapeutics)?
Which analyst is the currently most reserved on RLMD (Relmada Therapeutics)?
